Geneos Wealth Management Inc. Immuno Gen, Inc. Transaction History

Geneos Wealth Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$3.75 - $20.05 $1,125 - $6,015	300 New	300 $5,000
Q2 2021 Jul 08, 2021	SELL	$5.79 - $8.6 $1,325 - $1,969	-229 Closed	0 $0
Q1 2021 Jun 17, 2021	BUY	$6.5 - $10.53 $1,488 - $2,411	229 New	229 $1,000
Q4 2018 Sep 07, 2021	SELL	$3.94 - $9.7 $646 - $1,590	-164 Closed	0 $0
Q3 2017 Sep 07, 2021	BUY	$5.4 - $8.47 $885 - $1,389	164 New	164 $1,000
Q2 2016 Sep 07, 2021	SELL	N/A	-150 Closed	0 $0
Q1 2016 Sep 07, 2021	BUY	N/A	150	150 $1,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.